Cargando…

Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses

Feeding induces dopamine release in the striatum, and a dysfunction of the dopaminergic reward system can lead to overeating, and obesity. Studies have reported inconsistent findings of dopamine receptor (DR) positron emission tomography scans in obesity. Here we investigated the association between...

Descripción completa

Detalles Bibliográficos
Autores principales: Pak, Kyoungjune, Nummenmaa, Lauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681634/
https://www.ncbi.nlm.nih.gov/pubmed/37950852
http://dx.doi.org/10.1002/hbm.26534
_version_ 1785142587646017536
author Pak, Kyoungjune
Nummenmaa, Lauri
author_facet Pak, Kyoungjune
Nummenmaa, Lauri
author_sort Pak, Kyoungjune
collection PubMed
description Feeding induces dopamine release in the striatum, and a dysfunction of the dopaminergic reward system can lead to overeating, and obesity. Studies have reported inconsistent findings of dopamine receptor (DR) positron emission tomography scans in obesity. Here we investigated the association between DR availability and overweight/obesity using Bayesian and frequentist meta‐analysis. We performed a systematic search of Embase, Medline, Scopus and Web of Science for studies that compared striatal DR availability between lean subjects and overweight/obese subjects. The standardized mean difference (Hedge's g) of DR availability was calculated after extraction of data from each study. Studies were divided into two groups according to the definition of overweight/obese subjects (body mass index [BMI] cutoff of 25 and 30 kg/m(2)). Both Bayesian and frequentist meta‐analysis was done in R Statistical Software version 4.2.2 (The R Foundation for Statistical Computing). Nine studies were eligible for inclusion in this study. Three studies with C11‐raclopride, one with C11‐PNHO, two with F18‐fallypride, one with I123‐IBZM, one with C11‐NMB and one with both C11‐raclopride and C11‐PNHO were included. In Bayesian meta‐analysis, the standardized mean difference of DR availability between lean and overweight/obese subjects markedly overlapped with zero regardless of BMI cutoff for obesity. In frequentist meta‐analysis, the pooled standardized mean difference of DR availability did not show the significant difference between lean and overweight/obese subjects. There was an effect of the radiopharmaceutical on the standardized mean difference of DR availability in meta‐analysis of BMI cutoff of 25 kg/m(2). In conclusion, brain DR availability is not different between lean and overweight/obese subjects. However, the effect is dependent on the radiopharmaceutical and the degree of obesity. Further studies with multi‐radiopharmaceutical in the same individuals are needed to understand the association between DR and obesity.
format Online
Article
Text
id pubmed-10681634
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-106816342023-11-11 Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses Pak, Kyoungjune Nummenmaa, Lauri Hum Brain Mapp Research Articles Feeding induces dopamine release in the striatum, and a dysfunction of the dopaminergic reward system can lead to overeating, and obesity. Studies have reported inconsistent findings of dopamine receptor (DR) positron emission tomography scans in obesity. Here we investigated the association between DR availability and overweight/obesity using Bayesian and frequentist meta‐analysis. We performed a systematic search of Embase, Medline, Scopus and Web of Science for studies that compared striatal DR availability between lean subjects and overweight/obese subjects. The standardized mean difference (Hedge's g) of DR availability was calculated after extraction of data from each study. Studies were divided into two groups according to the definition of overweight/obese subjects (body mass index [BMI] cutoff of 25 and 30 kg/m(2)). Both Bayesian and frequentist meta‐analysis was done in R Statistical Software version 4.2.2 (The R Foundation for Statistical Computing). Nine studies were eligible for inclusion in this study. Three studies with C11‐raclopride, one with C11‐PNHO, two with F18‐fallypride, one with I123‐IBZM, one with C11‐NMB and one with both C11‐raclopride and C11‐PNHO were included. In Bayesian meta‐analysis, the standardized mean difference of DR availability between lean and overweight/obese subjects markedly overlapped with zero regardless of BMI cutoff for obesity. In frequentist meta‐analysis, the pooled standardized mean difference of DR availability did not show the significant difference between lean and overweight/obese subjects. There was an effect of the radiopharmaceutical on the standardized mean difference of DR availability in meta‐analysis of BMI cutoff of 25 kg/m(2). In conclusion, brain DR availability is not different between lean and overweight/obese subjects. However, the effect is dependent on the radiopharmaceutical and the degree of obesity. Further studies with multi‐radiopharmaceutical in the same individuals are needed to understand the association between DR and obesity. John Wiley & Sons, Inc. 2023-11-11 /pmc/articles/PMC10681634/ /pubmed/37950852 http://dx.doi.org/10.1002/hbm.26534 Text en © 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Pak, Kyoungjune
Nummenmaa, Lauri
Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
title Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
title_full Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
title_fullStr Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
title_full_unstemmed Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
title_short Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
title_sort brain dopamine receptor system is not altered in obesity: bayesian and frequentist meta‐analyses
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681634/
https://www.ncbi.nlm.nih.gov/pubmed/37950852
http://dx.doi.org/10.1002/hbm.26534
work_keys_str_mv AT pakkyoungjune braindopaminereceptorsystemisnotalteredinobesitybayesianandfrequentistmetaanalyses
AT nummenmaalauri braindopaminereceptorsystemisnotalteredinobesitybayesianandfrequentistmetaanalyses